FDA Accepts Biologics License Application For Aimovig™ (erenumab)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BJ
9. BABA
10. OSIS

Go back to FDA Accepts Biologics License Application For Aimovig™ (erenumab)
Amgen Inc (NASDAQ: AMGN) Delayed: 439.33 +5.60 (1.29%)
Previous Close $433.73    52 Week High $176.85 
Open $431.72    52 Week Low $133.64 
Day High $440.51    P/E 66.16 
Day Low $429.38    EPS $6.64 
Volume 2,114,259